Insider Transactions in Q4 2021 at Cvs Health Corp (CVS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2021
|
Alan Lotvin EVP&President-PharmacyServices |
SELL
Payment of exercise price or tax liability
|
Direct |
200
-3.32%
|
$17,600
$88.78 P/Share
|
|
Dec 01
2021
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
68
-0.4%
|
$5,984
$88.78 P/Share
|
|
Nov 28
2021
|
Karen S Lynch President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,121
-16.97%
|
$1,285,011
$91.52 P/Share
|
|
Nov 17
2021
|
Tony L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,314
+3.36%
|
$120,888
$92.73 P/Share
|
|
Nov 17
2021
|
Mary L Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
417
+5.21%
|
$38,364
$92.73 P/Share
|
|
Nov 17
2021
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,253
+50.0%
|
$115,276
$92.73 P/Share
|
|
Nov 17
2021
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,314
+50.0%
|
$120,888
$92.73 P/Share
|
|
Nov 17
2021
|
David W Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,154
+2.79%
|
$290,168
$92.73 P/Share
|
|
Nov 17
2021
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,334
+5.39%
|
$122,728
$92.73 P/Share
|
|
Nov 17
2021
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,253
+4.56%
|
$115,276
$92.73 P/Share
|
|
Nov 03
2021
|
Jonathan C Roberts EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
108,870
-50.41%
|
$10,342,650
$95.0 P/Share
|
|
Nov 03
2021
|
Jonathan C Roberts EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
108,870
+33.51%
|
$4,899,150
$45.93 P/Share
|
|
Nov 01
2021
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,159
-16.92%
|
$2,534,310
$90.0 P/Share
|
|
Nov 01
2021
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,159
+14.47%
|
$1,633,222
$58.34 P/Share
|
|
Oct 26
2021
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
82,757
-18.89%
|
$7,282,616
$88.0 P/Share
|
|
Oct 26
2021
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
80,802
+26.77%
|
$4,363,308
$54.19 P/Share
|